The clinical utility of the prostate specific membrane antigen reverse-transcription/polymerase chain reaction to detect circulating prostate cells: An analysis in healthy men and women

BJU International

Volumn 89, Issue 9, 2002, Pages 882-885

  Llanes, L ^a   Ferruelo, A ^a   Paez A ^a,b   Gomez J M ^a   Moreno, A ^a   Berenguer, A ^a,b  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b European Randomized Study of Screening for Prostate Cancer ^*  (Netherlands)

Author keywords

Prostate specific membrane antigen; Prostatic neoplasms; RT PCR

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; MESSENGER RNA; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RESTRICTION ENDONUCLEASE;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CIRCULATION; FEMALE; GENE SEQUENCE; GENETIC DIFFERENCE; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; INTRON; MEDICAL ASSESSMENT; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 0036096098     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2002.02774.x     Document Type: Article

References (20)

1. Incidence and significance of positive margins in radical prostatectomy specimens
2. Detection of hematogenous micrometastasis in patients with prostate cancer
3. A sensitive method for detection of a prostate tumor cell marker using the PCR
4. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific antigen and prostate-specific membrane antigen-based assays
5. Detection of circulating prostate cells by reverse transcriptase polymerase chain reaction (RT-PCR) of human glandular kallikrein (hK2) and prostate specific antigen (PSA) messages
6. Detection of prostate cancer cells circulation in peripheral blood by reverse transcription-PCR for hKLK2
7. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic patients
8. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen
9. Expression of the prostate-specific membrane antigen
10. Prostate-specific membrane antigen (PSM) is expressed in various human tissues. Implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread
11. The expression of prostate specific membrane antigen in peripheral blood leukocytes
12. Molecular staging of prostate cancer: Comparison of nested reverse transcription polymerase chain reaction assay using prostate-specific antigen versus prostate-specific membrane antigen as primer
13. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer
14. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells
15. Sensitive detection of prostatic hematogenous micrometastases using PSA and PSM-derived primers in the polymerase chain reaction
16. Combined nested RT-PCR assay for PSA and PSMA in prostate cancer patients: Correlation with pathological stage
17. Molecular staging of prostate cancer II. A comparison of the application of an enhanced RT-PCR assay for prostate specific antigen versus prostate specific membrane antigen
18. Detection of PSA or PSMA positive circulating cells in prostatic cancer patients: Clinical implications
19. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcriptase polymerase chain reaction assay based on prostate specific membrane antigen
20. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood